3,287
Views
2
CrossRef citations to date
0
Altmetric
Case Report

A journey through anticoagulant therapies in the treatment of left ventricular thrombus in post-COVID-19 heparin-induced thrombocytopenia: a case report

ORCID Icon, , , , , & show all

References

  • Salter BS, Weiner MM, Trinh MA, et al. Heparin-induced thrombocytopenia. J Am Coll Cardiol. 2016;67(21):2519–2532. doi:10.1016/j.jacc.2016.02.073
  • Staibano P, Arnold DM, Bowdish DME, et al. The unique immunological features of heparin-induced thrombocytopenia. Br J Haematol. 2017;177(2):198–207. doi:10.1111/bjh.14603
  • Nippert M, de Maistre E, Rodermann M, et al. [Treatment with lepirudin in heparin-induced thrombocytopenia. A case report]. Arch Mal Coeur Vaiss. 2002;95(12):1234–1238.
  • Vignon P, Guéret P, François B, et al. Acute limb ischemia and heparin-induced thrombocytopenia: the value of echocardiography in eliminating a cardiac source of arterial emboli. J Am Soc Echocardiogr. 1996;9(3):344–347. doi:10.1016/S0894-7317(96)90150-9
  • Daviet F, Guervilly C, Baldesi O, et al. Heparin-induced thrombocytopenia in severe COVID-19. Circulation. 2020;142(19):1875–1877. doi:10.1161/CIRCULATIONAHA.120.049015
  • Riker RR, May TL, Fraser GL, et al. Heparin-Induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome. Res Pract Thromb Haemost. 2020;4(5):936–941. doi:10.1002/rth2.12390
  • Ogawa Y, Nagata T, Akiyama T, et al. Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019. J Thromb Thrombolysis. 2020;50(4):1012–1014. doi:10.1007/s11239-020-02248-8
  • Lozano R, Franco ME. Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease. Med Clin (Engl Ed). 2020;155(9):409–410. doi:10.1016/j.medcle.2020.05.023
  • Huang CT, Hsu SY, Chang KW, et al. Heparin-induced thrombocytopenia and thrombosis in a patient with COVID-19. Thromb Res. 2020;196:11–14. doi:10.1016/j.thromres.2020.07.056
  • Phan XT, Nguyen TH, Tran TT, et al. Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report. Thromb J. 2020;18(1):37), doi:10.1186/s12959-020-00252-9
  • Sartori M, Cosmi B. Heparin-induced thrombocytopenia and COVID-19. Hematol Rep. 2021;13(1):8857. doi:10.4081/hr.2021.8857
  • Julian K, Bucher D, Jain R. Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19. BMJ Case Rep. 2021;14(5):e243315. doi:10.1136/bcr-2021-243315
  • Siddiqui NA, Luvsannyam E, Jain MS, et al. Acute limb ischemia complicated by heparin-induced thrombocytopenia in an asymptomatic COVID-19 patient. Cureus. 2021;13(7):e16162. doi:10.7759/cureus.16162
  • Warkentin TE, Kaatz S. COVID-19 versus HIT hypercoagulability. Thromb Res. 2020;196:38–51. doi:10.1016/j.thromres.2020.08.017
  • Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360–3392. doi:10.1182/bloodadvances.2018024489
  • Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia. Chest. 2012;141(2 Suppl.):e495S–e530S. doi:10.1378/chest.11-2303
  • Koster A, Erdoes G, Nagler M, et al. How would we treat our own heparin-induced thrombocytopenia during cardiac surgery? J Cardiothorac Vasc Anesth. 2021;35(6):1585–1593. doi:10.1053/j.jvca.2020.11.002